查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1901499

臨床前生物分析檢測服務市場：依工作流程、分子、檢測項目、最終用途、國家及地區分類－全球產業分析、市場規模、市場佔有率及2025-2032年預測

Preclinical Bioanalytical Testing Services Market, By Workflow, By Molecule, By Test, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 355 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年臨床前生物分析測試服務市場規模為 12.3456 億美元，從 2025 年到 2032 年以 9.5% 的複合年成長率成長。

臨床前生物分析檢測服務市場是一個合約研究和實驗室服務領域，透過在臨床試驗前分析候選藥物的藥物動力學 (PK)、毒理學、生物標記和生物利用度來支持藥物開發。這些服務提供可靠、合規且數據驅動的分子安全性和有效性評估。生物製劑和複雜療法數量的不斷成長需要先進的分析平台，這推動了市場成長。一個重要的趨勢是，高靈敏度液相層析-串聯質譜 (LC-MS/MS) 和自動化技術的日益普及，提高了檢測通量和資料準確性。然而，該市場也面臨著許多挑戰，例如高昂的營運成本和嚴格的監管要求，這些都會延長檢測週期。儘管有這些挑戰，製藥和生技公司外包業務的擴張，尤其是在特殊檢測和方法開發方面，代表著巨大的機遇，使得臨床前生物分析服務成為現代藥物發現流程中不可或缺的組成部分。

臨床前生物分析檢測服務市場—市場動態

慢性病盛行率上升推動市場成長

慢性病盛行率的上升預計將推動臨床前生物分析檢測服務市場的未來成長。慢性病是指持續三個月或更長時間且病情可能隨時間惡化的疾病。生物分析檢測服務有助於識別和測量與慢性病相關的特定生物標記物，以及進行治療藥物監測，確保患者體內的藥物濃度保持在治療範圍內。例如，根據美國國家醫學圖書館（一家總部位於美國的機構）的數據顯示，到2050年，美國50歲及以上患有至少一種慢性病的人口數量將增加99.5%，即1.4266億。此外，總部位於瑞士的政府間衛生組織－世界衛生組織（WHO）在2022年報告中指出，2022年9月全球共有4,100萬人死於非傳染性疾病（NCD）或慢性病，佔全球所有非傳染性疾病死亡人數的74%。因此，慢性病盛行率的上升推動了臨床前生物分析測試服務產業的擴張。

臨床前生物分析檢測服務市場細分分析：

全球臨床前生物分析測試服務市場按工作流程、分子、測試、最終用途和地區進行細分。

根據測試結果，生物利用度測試將成為生物分析檢測服務市場中最重要的細分領域。生物利用度對於確定新藥在臨床試驗給藥後的藥物動力學特徵至關重要。此外，目前正在進行的臨床試驗數量也不斷增加。因此，將生物利用度測試納入這些試驗對於確保所用製劑的一致性和穩定性至關重要，最終有助於改善患者的治療效果。例如，根據世界衛生組織國際臨床試驗註冊平台（ICTRP）於2023年2月發布的報告，2022年西太平洋地區的臨床試驗註冊數量顯著增加。這一成長主要歸功於中國和日本大量的臨床試驗註冊，兩國分別位列該地區第一和第二。

依工作流程分類，樣品採集和製備領域憑藉其選擇性、便利性、速度和萃取階段配置等優勢，佔據了市場主導地位。為滿足日益成長的自動化、減少溶劑用量和小型化需求，技術驅動的樣品製備方法正在不斷發展，從而實現現場、原位和體內應用。例如，2023年11月，賽默飛世爾科技推出了體外診斷 (IVD) 和體外診斷法規 (IVD-R) 認證實驗室的自動化樣品製備解決方案。這些新解決方案將有助於改進和自動化呼吸系統診斷檢測。

臨床前生物分析檢測服務市場—地域洞察

北美憑藉其創新精神和完善的基礎設施，在臨床前生物分析檢測服務市場中脫穎而出。該地區擁有成熟且完善的設施。尤其值得一提的是，美國擁有龐大的製藥和生技產業，因此對生物分析檢測服務的需求十分旺盛。此外，該地區嚴格的FDA監管確保製藥公司維持高標準的檢測質量，這也使得生物分析檢測服務不可或缺。因此，各大公司正在拓展其檢測服務組合，以滿足不斷成長的需求。 2024年8月，SGS Societe Generale de Surveillance SA在Agilex Biolabs Pty Ltd的協助下，在北美推出了全新的生物分析檢測服務。此次業務拓展擴大了檢測解決方案的範圍，並透過為臨床試驗和藥物研發提供全面支持，促進了市場成長。

美國臨床前生物分析檢測服務市場—國家概況

由於對精準醫療的需求不斷成長，以及生物製劑和生物相似藥研發管線的不斷擴充，美國市場正迅速擴張。根據產業報告顯示，截至2024年12月，美國已有64種生物相似藥獲批上市，凸顯了美國在生物製劑創新領域的領先地位，以及由此帶來的對生物分析驗證的龐大需求。藥物研發中藥物動力學和藥效學研究的重要性日益凸顯，也增加了專業分析方法的需求。此外，生命科學研究經費的增加以及對監管合規性的嚴格要求，促使生物分析檢測外包，以確保資料品質的一致性。在分析工作流程中應用高通量篩選和液相層析串聯質譜（LC-MS/MS）等尖端技術，能夠提高結果的準確性並縮短週轉時間。

目錄

第1章：臨床前生物分析檢測服務市場概述

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
  • 競爭洞察

第3章：臨床前生物分析檢測服務主要市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場未來趨勢

第4章：臨床前生物分析測試服務產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：臨床前生物分析檢測服務市場：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：臨床前生物分析檢測服務市場概況

  • 2024年臨床前生物分析檢測服務市佔率分析
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：臨床前生物分析測試服務市場：依工作流程分類

  • 概述
    • 細分市場佔有率分析：依工作流程
    • 樣品分析
      • 連字符技術
      • 色譜技術
      • 電泳
      • 配體結合試驗
      • 質譜分析
      • 光譜技術
      • 基因組學和分子技術
    • 方法開發與驗證
    • 樣本採集與製備
      • 樣本採集、處理和儲存
      • 蛋白質沉澱
      • 液態萃取
      • 固相萃取
      • 其他
    • 其他流程

第8章：臨床前生物分析測試服務市場：依分子分類

  • 概述
    • 細分市佔率分析：按分子
    • 小分子
    • 大分子

第9章：臨床前生物分析檢測服務市場：依檢測方式分類

  • 概述
    • 細分市場佔有率分析：按測試
    • 生物利用度
    • 生物等效性
    • 生物標記檢測
    • ADME
      • 體內
      • 體外
    • 藥物動力學（PK）
    • 藥效學（PD）
    • 基於細胞的檢測
    • 病毒學檢測
    • 其他測試

第10章：臨床前生物分析測試服務市場：依最終用途分類

  • 概述
    • 細分市佔率分析：按分子
    • CDMO
    • 信用評等機構
    • 製藥和生物製藥公司
    • 其他

第11章：臨床前生物分析檢測服務市場：依地域分類

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • その他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • その他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • その他

第12章：主要供應商分析：臨床前生物分析檢測服務業

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • Charles River Laboratories International
    • Syneos Health
    • SGS SA
    • WuXi AppTec
    • Thermo Fisher Scientific Inc (PPD, Inc.)
    • Parexel International
    • Pharmaron
    • BioAgilytix Labs
    • KCAS Bio
    • ICON plc
    • Labcorp
    • Eurofins Scientific SE
    • QPS Holdings
    • Altasciences
    • Others

第13章：360度AnalystView

簡介目錄
Product Code: ANV5825

Preclinical Bioanalytical Testing Services Market size was valued at US$ 1,234.56 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

The Preclinical Bioanalytical Testing Services Market is a contract research and laboratory services segment that supports drug development by analyzing drug candidates' pharmacokinetics (PK), toxicology, biomarkers, and bioavailability prior to clinical trials. These services provide a reliable, compliant, and data-driven assessment of a molecule's safety and efficacy. The increasing number of biologics and complex modalities that require advanced analytical platforms is driving market growth. An important trend is the growing use of high-sensitivity LC-MS/MS and automation to improve throughput and data accuracy. However, the market faces constraints such as high operational costs and stringent regulatory expectations, which lengthen testing timelines. Despite these challenges, the expansion of outsourcing by pharmaceutical and biotechnology companies, particularly for specialty assays and method development, represents a significant opportunity, making preclinical bioanalytical services an essential component of modern drug discovery pipelines.

Preclinical Bioanalytical Testing Services Market- Market Dynamics

Increasing Prevalence of Chronic Diseases Propel Growth In The Market

The rising prevalence of chronic diseases is expected to drive future growth in the preclinical bioanalytical testing services market. Chronic disease is a type of illness that lasts three months or longer and can deteriorate over time. Bioanalytical testing services assist in identifying and measuring specific biomarkers associated with chronic diseases, as well as therapeutic drug monitoring, ensuring that drug levels in the patient's body remain within the therapeutic range. For instance, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least one chronic condition will rise by 99.5%, or 142.66 million, by 2050. Furthermore, the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, reported 41 million deaths in September 2022, accounting for 74% of all deaths caused by noncommunicable diseases (NCDs) or chronic diseases worldwide. As a result, the rising prevalence of chronic diseases fuels the expansion of the Preclinical bioanalytical testing services industry.

Preclinical Bioanalytical Testing Services Market- Segmentation Analysis:

The Global Preclinical Bioanalytical Testing Services Market is segmented by Workflow, Molecule, Test, End Use and Region.

According to the test, the bioavailability test segment will be the most important in the market for bioanalytical testing services. Bioavailability is critical in determining the efficacy of a new drug's pharmacokinetic profile after administration in clinical trials. Furthermore, there has been an increase in the number of active clinical trials. As a result, incorporating bioavailability testing into these trials is critical to ensuring consistency and stability among formulations used, ultimately improving patient outcomes. For instance, according to a report published in February 2023 by the WHO International Clinical Trials Registry Platform (ICTRP), clinical trial registrations in the Western Pacific region increased significantly in 2022. This increase is primarily due to the large number of clinical trial registrations in China and Japan, which rank first and second in the region, respectively.

By Workflow, the Sample Collection and Preparation segment takes over the market due to its selectivity, convenience, speed, and extraction phase configurations. Technology-driven sample preparations are being developed to meet the growing demand for automation, reduced solvent usage, and miniaturization, resulting in on-site, in situ, and in vivo applications. For example, in November 2023, Thermo Fisher Scientific introduced automated sample preparation solutions for laboratories certified for in vitro diagnostics (IVD) and in vitro diagnostic regulation (IVD-R). The new solutions will help to improve and automate respiratory diagnostic testing.

Preclinical Bioanalytical Testing Services Market- Geographical Insights

North America stands out in the preclinical bioanalytical testing services market due to its innovative spirit and robust infrastructure. The region boasts well-established and developed facilities. The United States, in particular, has a high demand for bioanalytical testing services due to its large pharmaceutical and biotechnology industries. Furthermore, strict FDA regulations in the region ensure that pharmaceutical companies maintain high-quality testing standards, necessitating bioanalytical testing services. As a result, major companies are expanding their testing service portfolios to meet rising demand. In August 2024, SGS Societe Generale de Surveillance SA launched its new bioanalytical testing services in North America with the help of Agilex Biolabs Pty Ltd. This expansion expands testing solutions and boosts market growth by offering comprehensive support for clinical trials and drug development.

United States Preclinical Bioanalytical Testing Services Market- Country Insights

The US market is rapidly expanding, owing to increased demand for precision medicine and an expanding pipeline of biologics and biosimilars. According to industry reports, the United States had 64 approved biosimilars as of December 2024, demonstrating the country's leadership in biologics innovation and the resulting demand for bioanalytical validation. The growing importance of pharmacokinetic and pharmacodynamic studies in drug development has increased the demand for specialized analytical methods. Furthermore, increased funding for life sciences research and a strong emphasis on regulatory compliance have prompted the outsourcing of bioanalytical testing to ensure consistent data quality. The application of cutting-edge technologies in analytical workflows, such as high-throughput screening and LC-MS/MS, improves result accuracy and turnaround time.

Preclinical Bioanalytical Testing Services Market- Competitive Landscape:

The preclinical bioanalytical testing services market has a competitive landscape that includes a large number of players, ranging from established companies to emerging startups. The market is highly fragmented, with key players prioritizing strategic collaborations, mergers and acquisitions, and technological advancements to strengthen their market positions. The growing demand for specialized bioanalytical services, fueled by advances in pharmaceutical and biotechnology research, has increased competition, prompting businesses to broaden their service offerings and geographic reach. The emphasis on quality, dependability, and regulatory compliance remains a critical differentiator in this competitive environment. Major companies in the bioanalytical testing services market include Thermo Fisher Scientific Inc (PPD, Inc.), Parexel International, Pharmaron, and BioAgilytix Labs. These companies have established themselves as industry leaders, providing a wide range of bioanalytical services to pharmaceutical and biotechnology companies.

Recent Developments:

In June 2024, Lebanon, a New Jersey laboratory facility in Curia, was acquired by Pace Analytical Services. The acquisition will offer support to drug development partners that are new in the market by providing rapid and highly expert development and analytical laboratory services on a commercial basis across the biopharma sector.

In November of 2024, Altasciences stated that it has expanded its bioanalytical service portfolio by providing flexible, high-quality analytical solutions for preclinical and clinical studies, reinforcing its 30-year commitment to accelerating global drug development and client success.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Charles River Laboratories International
  • Syneos Health
  • SGS SA
  • WuXi AppTec
  • Thermo Fisher Scientific Inc (PPD, Inc.)
  • Parexel International
  • Pharmaron
  • BioAgilytix Labs
  • KCAS Bio
  • ICON plc
  • Labcorp
  • Eurofins Scientific SE
  • QPS Holdings
  • Altasciences
  • Others

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY WORKFLOW- MARKET ANALYSIS, 2019 - 2032

  • Sample Analysis
  • Hyphenated technique
  • Chromatographic technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Spectroscopic Techniques
  • Genomic and Molecular Techniques
  • Method Development and Validation
  • Sample Collection and Preparation
  • Sample Collection, Handling and Storage
  • Protein Precipitation
  • Liquid-Liquid Extraction
  • Solid Phase Extraction
  • Others
  • Other processes

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY MOLECULE- MARKET ANALYSIS, 2019 - 2032

  • Small Molecule
  • Large Molecule

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY TEST- MARKET ANALYSIS, 2019 - 2032

  • Bioavailability
  • Bioequivalence
  • Biomarker Testing
  • ADME
  • In-vivo
  • In-vitro
  • Pharmacokinetics (PK)
  • Pharmacodynamics (PD)
  • Cell-based Assay
  • Virology Testing
  • Other Tests

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • CDMO
  • CRO
  • Pharma & BioPharma Companies
  • Others

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Preclinical Bioanalytical Testing Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Preclinical Bioanalytical Testing Services Market Snippet by Workflow
    • 2.1.2. Preclinical Bioanalytical Testing Services Market Snippet by Molecule
    • 2.1.3. Preclinical Bioanalytical Testing Services Market Snippet by Test
    • 2.1.4. Preclinical Bioanalytical Testing Services Market Snippet by End Use
    • 2.1.5. Preclinical Bioanalytical Testing Services Market Snippet by Country
    • 2.1.6. Preclinical Bioanalytical Testing Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Preclinical Bioanalytical Testing Services Key Market Trends

  • 3.1. Preclinical Bioanalytical Testing Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Preclinical Bioanalytical Testing Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Preclinical Bioanalytical Testing Services Market Opportunities
  • 3.4. Preclinical Bioanalytical Testing Services Market Future Trends

4. Preclinical Bioanalytical Testing Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Preclinical Bioanalytical Testing Services Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Preclinical Bioanalytical Testing Services Market Landscape

  • 6.1. Preclinical Bioanalytical Testing Services Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Preclinical Bioanalytical Testing Services Market - By Workflow

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Workflow, 2024 & 2032 (%)
    • 7.1.2. Sample Analysis
      • 7.1.2.1. Hyphenated technique
      • 7.1.2.2. Chromatographic technique
      • 7.1.2.3. Electrophoresis
      • 7.1.2.4. Ligand Binding Assay
      • 7.1.2.5. Mass Spectrometry
      • 7.1.2.6. Spectroscopic Techniques
      • 7.1.2.7. Genomic and Molecular Techniques
    • 7.1.3. Method Development and Validation
    • 7.1.4. Sample Collection and Preparation
      • 7.1.4.1. Sample Collection, Handling and Storage
      • 7.1.4.2. Protein Precipitation
      • 7.1.4.3. Liquid-Liquid Extraction
      • 7.1.4.4. Solid Phase Extraction
      • 7.1.4.5. Others
    • 7.1.5. Other processes

8. Preclinical Bioanalytical Testing Services Market - By Molecule

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Molecule, 2024 & 2032 (%)
    • 8.1.2. Small Molecule
    • 8.1.3. Large Molecule

9. Preclinical Bioanalytical Testing Services Market - By Test

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Test, 2024 & 2032 (%)
    • 9.1.2. Bioavailability
    • 9.1.3. Bioequivalence
    • 9.1.4. Biomarker Testing
    • 9.1.5. ADME
      • 9.1.5.1. In-vivo
      • 9.1.5.2. In-vitro
    • 9.1.6. Pharmacokinetics (PK)
    • 9.1.7. Pharmacodynamics (PD)
    • 9.1.8. Cell-based Assay
    • 9.1.9. Virology Testing
    • 9.1.10. Other Tests

10. Preclinical Bioanalytical Testing Services Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Molecule, 2024 & 2032 (%)
    • 10.1.2. CDMO
    • 10.1.3. CRO
    • 10.1.4. Pharma & BioPharma Companies
    • 10.1.5. Others

11. Preclinical Bioanalytical Testing Services Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Preclinical Bioanalytical Testing Services Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Preclinical Bioanalytical Testing Services Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Charles River Laboratories International
    • 12.2.2. Syneos Health
    • 12.2.3. SGS SA
    • 12.2.4. WuXi AppTec
    • 12.2.5. Thermo Fisher Scientific Inc (PPD, Inc.)
    • 12.2.6. Parexel International
    • 12.2.7. Pharmaron
    • 12.2.8. BioAgilytix Labs
    • 12.2.9. KCAS Bio
    • 12.2.10. ICON plc
    • 12.2.11. Labcorp
    • 12.2.12. Eurofins Scientific SE
    • 12.2.13. QPS Holdings
    • 12.2.14. Altasciences
    • 12.2.15. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us